Subscribe: E-mail | RSS
Phyllis D. Frosst

Phyllis Frosst is the head of Policy and Program Analysis at the National Human Genome Research Institute and a contractor for the National Institutes of Health. This piece represents her personal and professional views, not necessarily those of the US government.

23 February 2009

Despite uncertainties, companies are already selling genetic information to the public. Is this opportunism or consumer empowerment? And more important, what are the implications for the future of genomic medicine?

Read more...

  • Comment on this articleComment [2]
  • Link to this articleLink to this
  • Bookmark and Share this article Share

Send an e-mail to let us know how we can make our site better.